Essex Savings Bank’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,620
Closed -$222K 285
2024
Q2
$222K Hold
1,620
0.06% 240
2024
Q1
$220K Hold
1,620
0.06% 239
2023
Q4
$220K Buy
+1,620
New +$198K 0.06% 238
2023
Q3
Sell
-1,620
Closed -$206K 237
2023
Q2
$206K Hold
1,620
0.07% 220
2023
Q1
$209K Sell
1,620
-248
-13% -$32.5K 0.07% 214
2022
Q4
$245K Hold
1,868
0.09% 194
2022
Q3
$218K Sell
1,868
-20
-1% -$2.48K 0.09% 193
2022
Q2
$222K Sell
1,888
-570
-23% -$67.7K 0.08% 191
2022
Q1
$320K Hold
2,458
0.11% 164
2021
Q4
$375K Hold
2,458
0.13% 148
2021
Q3
$423K Hold
2,458
0.15% 138
2021
Q2
$373K Sell
2,458
-40
-2% -$6.16K 0.14% 148
2021
Q1
$392K Hold
2,498
0.17% 134
2020
Q4
$378K Hold
2,498
0.17% 133
2020
Q3
$338K Hold
2,498
0.17% 132
2020
Q2
$341K Sell
2,498
-45
-2% -$5.74K 0.2% 117
2020
Q1
$274K Hold
2,543
0.2% 117
2019
Q4
$307K Hold
2,543
0.16% 133
2019
Q3
$253K Sell
2,543
-1,960
-44% -$205K 0.13% 149
2019
Q2
$491K Buy
4,503
+2,400
+114% +$255K 0.17% 122
2019
Q1
$235K Hold
2,103
0.13% 129
2018
Q4
$203K Buy
+2,103
New +$223K 0.13% 133

Other funds holding IBB

Essex Savings Bank's IBB Position: Q3 2024 in Review

Essex Savings Bank sold out of iShares Biotechnology ETF (IBB) in Q3 2024, closing a stake of 1,620 shares — an estimated $222K sold.

Essex Savings Bank first reported a position in IBB in Q4 2018 and held it in 22 quarters. The position peaked at $491K in Q2 2019. 894 funds tracked by Wall St. Rank hold IBB as of Q3 2024.

  • Essex Savings Bank reported no remaining iShares Biotechnology ETF position as of Q3 2024 after selling out during the quarter.
  • Essex Savings Bank sold 1,620 iShares Biotechnology ETF shares in Q3 2024, an estimated $222K.
  • Essex Savings Bank first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 22 quarters.
  • Essex Savings Bank's iShares Biotechnology ETF position peaked at $491K in Q2 2019.
  • 894 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.

Based on Essex Savings Bank's 13F filing for Q3 2024, filed 1 Nov 2024.